Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verena S Hoffmann

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Leukemia|April 15, 2025
Prognostic scoring systems in chronic myeloid leukaemiaMichael Lauseker, Verena S Hoffmann, Markus Pfirrmann
Frontiers in Digital Health|December 1, 2025
Assessing patient preferences for medical decision making - a comparison of different methodsJakub Fusiak, Andreas Wolkenstein, Verena S Hoffmann
JBI Evidence Synthesis|August 28, 2024
Methods to incorporate patient preferences into medical decision algorithms and models, and their quantification, balancing, and evaluation: a scoping review protocolJakub Fusiak, Ulrich Mansmann, Verena S Hoffmann
Journal of the American College of Cardiology|March 12, 2014
Reply: Carotid plaque hemorrhage on magnetic resonance imaging and recurrent cerebrovascular eventsTobias Saam, Holger Hetterich, Verena S Hoffmann, et al.
Annals of Hematology|March 28, 2015
Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of deathMarkus Pfirrmann, Michael Lauseker, Verena S Hoffmann, et al.
Haematologica|May 5, 2012
Comment on "Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed" Haematologica 2011;96(12):1779-82Michael Lauseker, Markus Pfirrmann, Verena S Hoffmann, et al.
BMC Medical Informatics and Decision Making|March 3, 2025
Practical applications of methods to incorporate patient preferences into medical decision models: a scoping reviewJakub Fusiak, Kousha Sarpari, Inger Ma, et al.
BMC Medical Research Methodology|August 29, 2024
Distributed non-disclosive validation of predictive models by a modified ROC-GLMDaniel Schalk, Raphael Rehms, Verena S Hoffmann, et al.
Journal of Cancer Research and Clinical Oncology|March 10, 2017
Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemiaVerena S Hoffmann, Joerg Hasford, Michael Deininger, et al.
Annals of Hematology|December 4, 2014
A multi-state model approach for prediction in chronic myeloid leukaemiaMichael Lauseker, Joerg Hasford, Verena S Hoffmann, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Leukemia|April 15, 2025
Prognostic scoring systems in chronic myeloid leukaemiaMichael Lauseker, Verena S Hoffmann, Markus Pfirrmann
Frontiers in Digital Health|December 1, 2025
Assessing patient preferences for medical decision making - a comparison of different methodsJakub Fusiak, Andreas Wolkenstein, Verena S Hoffmann
JBI Evidence Synthesis|August 28, 2024
Methods to incorporate patient preferences into medical decision algorithms and models, and their quantification, balancing, and evaluation: a scoping review protocolJakub Fusiak, Ulrich Mansmann, Verena S Hoffmann
Journal of the American College of Cardiology|March 12, 2014
Reply: Carotid plaque hemorrhage on magnetic resonance imaging and recurrent cerebrovascular eventsTobias Saam, Holger Hetterich, Verena S Hoffmann, et al.
Annals of Hematology|March 28, 2015
Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of deathMarkus Pfirrmann, Michael Lauseker, Verena S Hoffmann, et al.
Haematologica|May 5, 2012
Comment on "Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed" Haematologica 2011;96(12):1779-82Michael Lauseker, Markus Pfirrmann, Verena S Hoffmann, et al.
BMC Medical Informatics and Decision Making|March 3, 2025
Practical applications of methods to incorporate patient preferences into medical decision models: a scoping reviewJakub Fusiak, Kousha Sarpari, Inger Ma, et al.
BMC Medical Research Methodology|August 29, 2024
Distributed non-disclosive validation of predictive models by a modified ROC-GLMDaniel Schalk, Raphael Rehms, Verena S Hoffmann, et al.
Journal of Cancer Research and Clinical Oncology|March 10, 2017
Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemiaVerena S Hoffmann, Joerg Hasford, Michael Deininger, et al.
Annals of Hematology|December 4, 2014
A multi-state model approach for prediction in chronic myeloid leukaemiaMichael Lauseker, Joerg Hasford, Verena S Hoffmann, et al.
Pageof 3